Close Menu

chlamydia

This article has been updated from a previous version to clarify the current test menu for BD's platforms.

Scientists from Network Biosystems have published research demonstrating that the company's rapid, point-of-care system for diagnosing and differentiating Chlamydia trachomatis strains achieved greater sensitivity and specificity than a commercially available PCR-based

Cepheid said last week that it has received clearance from the US Food and Drug Administration to market Xpert CT/NG on its GeneXpert system.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Cepheid's Xpert CT/NG test for marketing, the Sunnyvale, Calif.-based company announced after the close of the market on Thursday.

Meridian Bioscience has developed a simple, equipment-free, rapid nucleic acid purification method for use with a variety of clinical specimens, and demonstrated that it enables similar analytical and clinical sensitivity as current commonly used methods such as silica-based puri

Meridian Bioscience said this week that it has completed beta trials for two new Illumigene molecular amplification tests.

The primary motivation for PerkinElmer's acquisition of Chinese infectious disease diagnostic firm Shanghai Haoyuan Biotech, announced this week, is to provide the Waltham, Mass.-based firm entrée into the nucleic acid-based blood screening market, company executives said this we

A Cepheid executive today provided investors with an update on the company's molecular diagnostic pipeline, stating that the firm currently has 14 tests in development for its automated GeneXpert platform and that it expects to offer the broadest test menu of any molecular diagno

NEW YORK (GenomeWeb News) – A Leerink Swann survey of diagnostic laboratories in Europe found that molecular-based testing continues to find traction with continued penetration strongest in methicillin-resistant Staphylococcus aureus testing and human papillomavirus testing.

Researchers from Children's Hospital Oakland Research Institute, Emory University, and Network Biosystems have been awarded a five-year grant from the National Institutes of Health to develop an assay for NetBio's integrated molecular testing system that will identify the biothre

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.